Abbott Diabetes Monitor Patent Revived By Fed. Circ.
During an ex parte re-examination, the USPTO had construed the references in Abbott's patents to an "electrochemical sensor" to mean a sensor that included wires and cables. Using that construction, it rejected Abbott's patents as anticipated or obvious in view of prior art.
To view the full article, register now.